title: Inappropriate use of steroid and pneumocystis jiroveci pneumonia: report of two cases.
authors.affiliation: National Research Institute of TB and Lung Disease, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran. tabarsi@nritld.ac.ir
authors.forename: P
authors.initials: P
authors.lastname: Tabarsi
authors.forename: M
authors.initials: M
authors.lastname: Mirsaeidi
authors.forename: M
authors.initials: M
authors.lastname: Amiri
authors.forename: S
authors.initials: S
authors.lastname: Karimi
authors.forename: M R
authors.initials: MR
authors.lastname: Masjedi
authors.forename: D
authors.initials: D
authors.lastname: Mansouri
mesh_terms: D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001706:Biopsy; D016535:Bronchial Hyperreactivity / Q000188:drug therapy; D001999:Bronchoscopy; D003422:Critical Care; D004300:Doping in Sports; D017809:Fatal Outcome; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008487:Medical History Taking; D045363:Pneumocystis carinii; D011020:Pneumonia, Pneumocystis / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology / Q000382:microbiology / Q000628:therapy; D011239:Prednisolone / Q000009:adverse effects*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
chemical_list: D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D011239:Prednisolone